A randomised study comparing the safety and immunogenicity of a conjugate vaccine combination containing meningococcal group C and pneumococcal capsular polysaccharide - CRM197 with a meningococcal group C conjugate vaccine in healthy infants: challenge phase
Background: A combination nonavalent pneumococcal-group C meningococcal conjugate vaccine (Pnc9-MenC) was previously found to be safe and immunogenic when administered to infants at 2, 3 and 4 monts. This study describes the persistence of immunity at 12 months of age and the immunologic response to...
Main Authors: | , , , , , , , , , , , |
---|---|
Other Authors: | |
Format: | Journal article |
Language: | English |
Published: |
Elsevier
2007
|
Subjects: |